| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8516581 | Neuropharmacology | 2018 | 30 Pages |
Abstract
This article is part of the Special Issue entitled 'Metabolic Impairment as Risk Factors for Neurodegenerative Disorders.'
Keywords
PGC-1αMPTPLRRK2PINK1sirtuinSIRTCaMKDJ-1AMPAAMPKGLP-1TSCATGmTORDIOGHSREGR-1SOD2MFNNSCAHNNRF-2HtrA2LC-3CREB1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineAMP-activated protein kinaseBDNFULKNAD+PTEN-induced putative kinase 1ROSamyloid-βα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acidAlzheimer's diseaseHuntington's diseaseParkinson's diseaselong term potentiationLTPleucine-rich repeat kinase 2forkhead boxDementiaBBBNeural stem cellSuperoxide dismutase 2dentate gyrusbrain derived neurotrophic factornuclear factor-like 2FoxOcalorie restrictionautophagy-relatedAdult hippocampal neurogenesisnicotinamide adenine dinucleotideMechanistic target of rapamycinGrowth hormoneearly growth response 1cAMP response element binding proteinmicrotubule associated protein 1 light chain 3Ca2+/calmodulin-dependent protein kinaseglucagon-like peptide-1diet-induced obesityGhrelinReactive oxygen speciesgrowth hormone secretagogue receptor
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Alwena H. Morgan, Daniel J. Rees, Zane B. Andrews, Jeffrey S. Davies,